MaxCyte (LON:MXCT) Stock Passes Below 50 Day Moving Average – Here’s What Happened

MaxCyte, Inc. (LON:MXCT)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 346 ($4.35) and traded as low as GBX 264 ($3.32). MaxCyte shares last traded at GBX 264 ($3.32), with a volume of 29,582 shares.

MaxCyte Stock Down 2.6 %

The company has a market capitalization of £348.49 million, a P/E ratio of -9.67 and a beta of 1.13. The company has a debt-to-equity ratio of 8.59, a current ratio of 9.81 and a quick ratio of 14.38. The company has a 50 day moving average of GBX 344.76 and a 200-day moving average of GBX 313.89.

About MaxCyte

MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients.